News
Resilience Demonstrates Lower Cost of Perfusion Bioreactor Process Using 908 Devices’ REBEL At-line Analyzer
908 Devices to Report First Quarter Financial Results on May 9, 2023
908 Devices Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Revenue Outlook
908 Devices to Participate in the Cowen 43rd Annual Healthcare Conference
908 Devices to Report Fourth Quarter and Full Year 2022 Financial Results on March 7, 2023
908 Devices Unveils New Glucose and Lactate On-Line Device for Bioprocess Monitoring and Control
MX908 Device Enables Correctional Facility Personnel to Quickly Identify Illegal Drugs in Incoming Mail
908 Devices Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Outlook
908 Devices Records Strong Momentum in Life Sciences Sector
908 Devices Launches Pesticide Identification Capability to Thwart Illegal Marijuana Growing Operations
908 Devices to Participate in Upcoming Investor Conferences
908 Devices to Report Third Quarter 2022 Financial Results on November 14, 2022
email Subscribe to Our Communications Signup to receive new product updates, technical tips and more.